Publications by authors named "Ulrike Dirmeier"

Claim this Profile
S
Stability and suitability for storage and distribution of Ad26.ZEBOV/MVA-BN®-Filo heterologous prime-boost Ebola vaccine.
Martinus A H Capelle, Lara Babich, J P Els van Deventer-Troost, Doris Salerno, Kelly Krijgsman, Ulrike Dirmeier

Eur J Pharm Biopharm· August 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A prophylactic multivalent vaccine against different filovirus species is immunogenic and provides protection from lethal infections with Ebolavirus and Marburgvirus species in non-human primates.
Benoit Callendret, Jort Vellinga, Kerstin Wunderlich, Ariane Rodriguez, Robin Steigerwald, Ulrike Dirmeier

PLoS One· April 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Correction: A prophylactic multivalent vaccine against different filovirus species is immunogenic and provides protection from lethal infections with Ebolavirus and Marburgvirus species in non-human primates.
Benoit Callendret, Jort Vellinga, Kerstin Wunderlich, Ariane Rodriguez, Robin Steigerwald, Ulrike Dirmeier

PLoS One· April 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Phase I Study of a Poxviral TRICOM-Based Vaccine Directed Against the Transcription Factor Brachyury.
Christopher R Heery, Claudia Palena, Sheri McMahon, Renee N Donahue, Lauren M Lepone, Ulrike Dirmeier

Clin Cancer Res· November 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Recombinant Modified Vaccinia Virus Ankara Generating Ebola Virus-Like Particles.
Marc Schweneker, Andrea S Laimbacher, Gert Zimmer, Susanne Wagner, Elisabeth M Schraner, Ulrike Dirmeier

J Virol· June 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A poxviral-based cancer vaccine the transcription factor twist inhibits primary tumor growth and metastases in a model of metastatic breast cancer and improves survival in a spontaneous prostate cancer model.
Anna R Kwilas, Andressa Ardiani, Ulrike Dirmeier, Cornelia Wottawah, Jeffery Schlom

Oncotarget· September 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A novel naturally occurring tandem promoter in modified vaccinia virus ankara drives very early gene expression and potent immune responses.
Sonia T Wennier, Kay Brinkmann, Charlotte Steinhäußer, Nicole Mayländer, Claudia Mnich, Ulrike Dirmeier

PLoS One· April 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Immunotherapy with MVA-BN®-HER2 induces HER-2-specific Th1 immunity and alters the intratumoral balance of effector and regulatory T cells.
Stefanie J Mandl, Ryan B Rountree, Katie Dalpozzo, Lisa Do, John R Lombardo, Ulrike Dirmeier

Cancer Immunol Immunother· January 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Exosome targeting of tumor antigens expressed by cancer vaccines can improve antigen immunogenicity and therapeutic efficacy.
Ryan B Rountree, Stefanie J Mandl, James M Nachtwey, Katie Dalpozzo, Lisa Do, Ulrike Dirmeier

Cancer Res· August 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Introduction of the six major genomic deletions of modified vaccinia virus Ankara (MVA) into the parental vaccinia virus is not sufficient to reproduce an MVA-like phenotype in cell culture and in mice.
Christine Meisinger-Henschel, Michaela Späth, Susanne Lukassen, Michael Wolferstätter, Heike Kachelriess, Ulrike Dirmeier

J Virol· October 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Latent membrane protein 1 of Epstein-Barr virus coordinately regulates proliferation with control of apoptosis.
Ulrike Dirmeier, Reinhard Hoffmann, Ellen Kilger, Ute Schultheiss, Cinthia Briseño

Oncogene· March 2005

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Active NF-kappaB signalling is a prerequisite for influenza virus infection.
Falk Nimmerjahn, Diana Dudziak, Ulrike Dirmeier, Gerd Hobom, Alexander Riedel

J Gen Virol· August 2004

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Latent membrane protein 1 of Epstein-Barr virus induces CD83 by the NF-kappaB signaling pathway.
Diana Dudziak, Arnd Kieser, Ulrike Dirmeier, Falk Nimmerjahn, Susanne Berchtold

J Virol· August 2003

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Latent membrane protein 1 is critical for efficient growth transformation of human B cells by epstein-barr virus.
Ulrike Dirmeier, Bernhard Neuhierl, Ellen Kilger, Gilbert Reisbach, Mark L Sandberg

Cancer Res· June 2003

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis